Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Howard I. Scher
Based on 166 articles published since 2007
||||
Expertise Level
The expertise of Howard I. Scher ranks in the
  • Top 0.01%
  • ... of 129,228 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 166 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Scher, H   ·   Scher, H I   ·   Scher, Howard I   ·   Scher, Howard
Work Locations
Details
Most likely:    Memorial Sloan-Kettering Cancer Center   Contact    
2017
  • Sage Bionetworks, Seattle, WA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Mathematics and Statistics, University of Turku, Turku, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Information Technology, University of Turku, Turku, Finland. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Department of Pathology (HUSLAB), Helsinki University Hospital, Helsinki, Finland. · Sanofi, Bridgewater, NJ, USA. · AstraZeneca, Gaithersburg, MD, USA. · IBM T J Watson Research Center, IBM, Yorktown Heights, NY, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Genitourinary Medical Oncology Program, Division of Hematology and Oncology, University of California, San Francisco, CA, USA. · Genitourinary Oncology Services, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: · Pubmed 27864015
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Department of Cancer Medicine, Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. · The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. · Medivation, Inc, San Francisco, California. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 27648814
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Englander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian, New York, NY 10065, USA. · Department of Pathology, New York University School of Medicine, New York, NY 10016, USA. · Yale School of Medicine, New Haven, CT 06511, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Englander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian, New York, NY 10065, USA; Institute for Computational Biomedicine, Weill Medical College, New York, NY 10065, USA. · Englander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian, New York, NY 10065, USA; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA. · Center of Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Departments of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Departments of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 29153843
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Epic Sciences, La Jolla, California. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28819021
  • From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Pubmed 28785765
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. · AstraZeneca, Gaithersburg, MD, USA. · Sanofi US, Bridgewater, NJ, USA. · Pfizer Inc, New York, NY, USA. · Project Data Sphere LLC, Cary, NC, USA. · Celgene Corporation, Summit, NJ, USA. · Mayo Medical Center, Rochester, MN, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Janssen, the Pharmaceutical Companies of Johnson & Johnson, New Brunswick, NJ, USA. · Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. · Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel. · Division of Medical Oncology, Department of Medicine, Columbia University/New York Presbyterian Hospital, Manhattan, NY, USA; James J Peters VA Medical Center, Bronx, NY, USA. · Division of Medical Oncology, Department of Medicine, Columbia University/New York Presbyterian Hospital, Manhattan, NY, USA; James J Peters VA Medical Center, Bronx, NY, USA. Electronic address: · Pubmed 27979599
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: · Epic Sciences, La Jolla, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27979426
2016
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. · Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC. · Department of Medicine, Duke University Medical Center, Durham, NC. · Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Millennium Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Inc., Cambridge, MA. · Department of Urology, Weill Cornell Medical College, New York, NY; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Weill Cornell Medical College, New York, NY. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address: · Pubmed 27765518
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York · Department of Radiology, Weill Cornell Medical College, New York, New York. · Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · ImaginAb, Inc., Inglewood, California; and. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27516450
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. · Medivation, Inc., San Francisco, California. · Astellas Pharma Global Development, Inc., Northbrook, Illinois. · Virginia Oncology Associates, Norfolk, Virginia. · Pubmed 26858312
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Science, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Leonard Wagner Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065, USA. · Department of Urology, University Hospital of the Ruhr-University of Bochum, Marien Hospital Herne, Herne, Germany. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Innovagen AB, Lund, Sweden. · Department of Biochemistry, University of Turku, Turku, Finland. · Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA. · Molecular Cytology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA. · Department of Medical Radiation Physics, Lund University, Lund, Sweden. · Departments of Biology and Biomedical and Translational Sciences, Rowan University, Glassboro, NJ 08028, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, U.K. · Department of Laboratory Medicine, Lund University, Malmö, Sweden. · Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Division of Urological Research, Department of Clinical Sciences, Lund University, Malmö, Sweden. · Pubmed 27903863
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and · Pubmed 27694177
  • Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; CNIO-IBIMA Genitourinary Cancer Unit, Department of Medical Oncology, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain. · Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Medical Affairs, Janssen Diagnostics, Beerse, Belgium. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, La Jolla, CA, USA. · MIRA Research Institute for Biomedical Technology and Technical Medicine, University of Twente, Twente, The Netherlands. · Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. Electronic address: · Pubmed 27289566
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Medicine, Weill Cornell Medical College, New York, New York. · Epic Sciences, La Jolla, California. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York5Department of Radiology, Weill Cornell Medical College, New York, New York. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York6Cancer Services, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27262168
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 27025318
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York. Institute for Precision Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York. · Epic Sciences, San Diego, California. · Institute for Precision Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York. · Institute for Precision Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, New York. · Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York. · Pubmed 26671992
  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Memorial Sloan Kettering Cancer Center, New York, NY. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, San Diego, CA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 26598756
2015
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 25544634
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America. · Lexidyne, Colorado Springs, Colorado, United States of America. · Janssen Global Services, South Raritan, New Jersey, United States of America. · Pubmed 26460686
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 25797385
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Division of Nuclear Medicine, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Division of Urological Cancers, Lund University, Lund, Sweden. · New York Oncology Hematology, Albany, New York. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26178426
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. · Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Radiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Dana-Farber Cancer Institute; Brigham & Women's Hospital; and Broad Institute, Boston, Massachusetts. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Department of Radiology, Weill Cornell Medical College, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Radiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Medicine, Weill Cornell Medical College, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26175541
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medivation Inc., San Francisco, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Pubmed 25698064
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Program, Massachusetts General Hospital, Boston, MA, USA. · Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Clinical Development, Exelixis, Inc., South San Francisco, CA, USA. · Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Genitourinary Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Urologic Surgery and Oncology, University of California San Francisco, San Francisco, CA, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Pinnacle Oncology Hematology, Scottsdale, AZ, USA. · Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24631409
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 26552950
  • 1] Department of Medicine, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Genitourinary Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Medicine, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Pubmed 26068399
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: · Department of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Renal Service, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 25559408
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
2014
  • From the Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, NY. · Pubmed 24857104
  • Department of Radiation Oncology, University of California, San Francisco, 1600 Divisadero Street, Suite H-1031, San Francisco, CA 94115, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA. · Pubmed 24840073
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Endocrine Sciences, LabCorp, Calabasas, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 24637537
  • Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Urologikum Hamburg, Hamburg, Germany. · Janssen Research & Development, Raritan, NJ, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Pubmed 24080993
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT, Utrecht, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 25201530
  • From the ‡Protein Center, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · From the ‡Protein Center, Memorial Sloan Kettering Cancer Center, New York, New York 10065; §Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · **Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138; · ‡‡Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · §§Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · ¶¶Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · §§Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065; ‖‖Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · §§Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065; ¶¶Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Laboratory Medicine, Lund University, University Hospital UMAS, Malmö, Sweden. · From the ‡Protein Center, Memorial Sloan Kettering Cancer Center, New York, New York 10065; §Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · Pubmed 25056937
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Computational Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 23954088
2013
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 23459624
2012
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY 10065, USA. · Pubmed 22894553
2011
  • Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. · Pubmed 21859988
  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 21483004
  • Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, and Weill Cornell Medical College, New York, New York, USA. · Pubmed 22046024
2010
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 20398925
2009
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 19213602
2008
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. · Pubmed 18309951
2007
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Weill Medical College of Cornell University, New York, New York, USA. · Pubmed 17332293
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From the *Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center; †Department of Medicine, Weill Cornell Medical College; and Departments of ‡Laboratory Medicine and §Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27749322
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2015
  • Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25800753
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, · Pubmed 25143071
  • From the Department of Radiology (H.A.V., C.W., J.J.F., A.W., D.A.G., S.M.L., H.H.), Department of Epidemiology and Biostatistics (D.K., M.G.), and Genitourinary Oncology Service, Department of Medicine (M.J.M., H.I.S.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and Department of Radiology, Oncology and Radiations Sciences, Section of Radiology, Nuclear Medicine and PET, Uppsala University, Uppsala, Sweden (C.W.). · Pubmed 24475817
2013
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23806501
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23337756
  • 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK [2] Memorial Sloan-Kettering Cancer Center (MSKCC) and Weill Cornell Medical College, Center for Prostate and Urologic Cancers, New York, NY, USA. · Pubmed 24169353
  • Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Mithat Gönen, Martin Fleisher, Steven M. Larson, Charles L. Sawyers, and Howard I. Scher, Memorial Sloan-Kettering Cancer Center; Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Steven M. Larson, and Howard I. Scher, Weill Cornell Medical College, New York, NY; Jeffrey H. Hager, Peter J. Rix, Edna Chow Maneval, and Isan Chen, Aragon Pharmaceuticals, San Diego, CA; and Charles L. Sawyers, Howard Hughes Medical Institute, Chevy Chase, MD. · Pubmed 24002508
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23820963
  • Authors' Affiliations: Weill Cornell Medical College (WCMC); Weill Cornell Cancer Center; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York; and University of North Carolina Chapel Hill, North Carolina. · Pubmed 23714732
  • Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 23653243
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, NY 10065, USA. · Pubmed 23535954
  • Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 23246260
  • Authors' Affiliations: Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center; Departments of Surgery, Medicine, Pathology, Biostatistics, and Immunology, Memorial Sloan-Kettering Cancer Center; NYU Langone Medical Center, New York; Department of Immunology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama; RIKEN Bioresource Center, Tsukuba, Ibaraki, Japan; and Klinik für Onkologie und Hämatologie, Krankenhaus Nordwest, Frankfurt, Germany. · Pubmed 24081977
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Pubmed 23817021
  • Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 23765638
  • Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York, USA. · Pubmed 23348745
2012
  • Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 22528368
  • Human Oncology and Pathogenesis Program and Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 22231760
  • Department of Medicine, Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, NY 10065, USA. · Pubmed 22553195
  • Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 22919006
  • Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Pubmed 22266222
  • Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 22231045
2011
  • Genitourinary Oncology Service, Department of Medicine and Department of Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21680546
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21802835
  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. · Pubmed 21131556
  • Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 21984797
  • Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 21604939
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21575859
2010
  • Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 20975102
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 20217089
  • Department of Medicine, Joan and Sanford E. Weill College of Medicine of Cornell University, Ithaca, NY, USA. · Pubmed 20159814
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 21107093
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York 10022, USA. · Pubmed 20665492
  • Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 20579941
  • Department of Medicine, Clinical Genetics Service, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, Albert Einstein College of Medicine, New York, New York 10065, USA. · Pubmed 20460480
  • Clinical Genetics Service, Department of Medicine, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 20215531
  • Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 20080885
2009
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 19815486
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19375217
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19364960
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19359544
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19796750
  • Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 36, New York, NY 10065, USA. · Pubmed 19628766
  • Molecular Cytogenetics Core Laboratory, Department of Medicine, Memorial Sloan-kettering Cancer Center, New York, New York, USA. · Pubmed 19276271
  • Departments of Surgery (Urology Service), Memorial Sloan-Kettering Cancer Center,New York, NY 10065, USA. · Pubmed 19233911
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19213669
  • Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. · Pubmed 19190343
  • Department of Surgery (Urology Service), Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 19003994
2008
  • Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 18674639
  • Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 18565882
  • Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 18552139
  • Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 18362364
  • Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 18661513
2007
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 17925542
  • Department of Medicine (Genitourinary Oncology Service), Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 17936848
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. · Pubmed 17619878
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 18056182
  • Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 17761958
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 17557117
Probable:    Cornell University      
2017
  • Sage Bionetworks, Seattle, WA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Mathematics and Statistics, University of Turku, Turku, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Information Technology, University of Turku, Turku, Finland. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Department of Pathology (HUSLAB), Helsinki University Hospital, Helsinki, Finland. · Sanofi, Bridgewater, NJ, USA. · AstraZeneca, Gaithersburg, MD, USA. · IBM T J Watson Research Center, IBM, Yorktown Heights, NY, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Genitourinary Medical Oncology Program, Division of Hematology and Oncology, University of California, San Francisco, CA, USA. · Genitourinary Oncology Services, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: · Pubmed 27864015
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Epic Sciences, La Jolla, California. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28819021
  • From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Pubmed 28785765
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: · Epic Sciences, La Jolla, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27979426
2016
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. · Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC. · Department of Medicine, Duke University Medical Center, Durham, NC. · Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Millennium Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Inc., Cambridge, MA. · Department of Urology, Weill Cornell Medical College, New York, NY; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Weill Cornell Medical College, New York, NY. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address: · Pubmed 27765518
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York · Department of Radiology, Weill Cornell Medical College, New York, New York. · Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · ImaginAb, Inc., Inglewood, California; and. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27516450
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Science, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Leonard Wagner Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065, USA. · Department of Urology, University Hospital of the Ruhr-University of Bochum, Marien Hospital Herne, Herne, Germany. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Innovagen AB, Lund, Sweden. · Department of Biochemistry, University of Turku, Turku, Finland. · Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA. · Molecular Cytology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA. · Department of Medical Radiation Physics, Lund University, Lund, Sweden. · Departments of Biology and Biomedical and Translational Sciences, Rowan University, Glassboro, NJ 08028, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, U.K. · Department of Laboratory Medicine, Lund University, Malmö, Sweden. · Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Division of Urological Research, Department of Clinical Sciences, Lund University, Malmö, Sweden. · Pubmed 27903863
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Medicine, Weill Cornell Medical College, New York, New York. · Epic Sciences, La Jolla, California. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York5Department of Radiology, Weill Cornell Medical College, New York, New York. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York6Cancer Services, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27262168
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 27025318
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Memorial Sloan Kettering Cancer Center, New York, NY. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, San Diego, CA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 26598756
2015
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 25544634
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America. · Lexidyne, Colorado Springs, Colorado, United States of America. · Janssen Global Services, South Raritan, New Jersey, United States of America. · Pubmed 26460686
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Division of Nuclear Medicine, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Division of Urological Cancers, Lund University, Lund, Sweden. · New York Oncology Hematology, Albany, New York. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26178426
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. · Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Radiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Dana-Farber Cancer Institute; Brigham & Women's Hospital; and Broad Institute, Boston, Massachusetts. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Department of Radiology, Weill Cornell Medical College, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Radiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Medicine, Weill Cornell Medical College, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26175541
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medivation Inc., San Francisco, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Pubmed 25698064
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Program, Massachusetts General Hospital, Boston, MA, USA. · Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Clinical Development, Exelixis, Inc., South San Francisco, CA, USA. · Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Genitourinary Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Urologic Surgery and Oncology, University of California San Francisco, San Francisco, CA, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Pinnacle Oncology Hematology, Scottsdale, AZ, USA. · Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24631409
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
2014
  • From the Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, NY. · Pubmed 24857104
  • Department of Radiation Oncology, University of California, San Francisco, 1600 Divisadero Street, Suite H-1031, San Francisco, CA 94115, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA. · Pubmed 24840073
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Endocrine Sciences, LabCorp, Calabasas, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 24637537
  • Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Urologikum Hamburg, Hamburg, Germany. · Janssen Research & Development, Raritan, NJ, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Pubmed 24080993
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT, Utrecht, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 25201530
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Computational Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 23954088
2012
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY 10065, USA. · Pubmed 22894553
2011
  • Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, and Weill Cornell Medical College, New York, New York, USA. · Pubmed 22046024
2007
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Weill Medical College of Cornell University, New York, New York, USA. · Pubmed 17332293
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From the *Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center; †Department of Medicine, Weill Cornell Medical College; and Departments of ‡Laboratory Medicine and §Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27749322
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2015
  • Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25800753
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
2013
  • 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK [2] Memorial Sloan-Kettering Cancer Center (MSKCC) and Weill Cornell Medical College, Center for Prostate and Urologic Cancers, New York, NY, USA. · Pubmed 24169353
  • Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Mithat Gönen, Martin Fleisher, Steven M. Larson, Charles L. Sawyers, and Howard I. Scher, Memorial Sloan-Kettering Cancer Center; Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Steven M. Larson, and Howard I. Scher, Weill Cornell Medical College, New York, NY; Jeffrey H. Hager, Peter J. Rix, Edna Chow Maneval, and Isan Chen, Aragon Pharmaceuticals, San Diego, CA; and Charles L. Sawyers, Howard Hughes Medical Institute, Chevy Chase, MD. · Pubmed 24002508
  • Authors' Affiliations: Weill Cornell Medical College (WCMC); Weill Cornell Cancer Center; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York; and University of North Carolina Chapel Hill, North Carolina. · Pubmed 23714732
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
2010
  • Department of Medicine, Joan and Sanford E. Weill College of Medicine of Cornell University, Ithaca, NY, USA. · Pubmed 20159814
Probable:    NewYork-Presbyterian Hospital      
2014
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT, Utrecht, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 25201530
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 166 total) written by Howard I. Scher about Prostatic Neoplasms:

  • Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. 2017
  • The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population. 2017
  • Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial. 2017
  • Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. 2017
  • Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer. 2017
  • Maintaining Bone Health During Hormonal Therapy for Prostate Cancer. 2017
  • Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel. 2017
  • Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis. 2017
  • Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer. 2017
  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. 2016
Show List of Full Article Records
Google Searches

Learn more about Howard I. Scher using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Memorial Sloan-Kettering Cancer Center
Cornell University
NewYork-Presbyterian Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Memorial Sloan-Kettering Cancer Center
2017
  • Sage Bionetworks, Seattle, WA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Mathematics and Statistics, University of Turku, Turku, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Information Technology, University of Turku, Turku, Finland. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Department of Pathology (HUSLAB), Helsinki University Hospital, Helsinki, Finland. · Sanofi, Bridgewater, NJ, USA. · AstraZeneca, Gaithersburg, MD, USA. · IBM T J Watson Research Center, IBM, Yorktown Heights, NY, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Genitourinary Medical Oncology Program, Division of Hematology and Oncology, University of California, San Francisco, CA, USA. · Genitourinary Oncology Services, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: · Pubmed 27864015
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Department of Cancer Medicine, Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. · The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. · Medivation, Inc, San Francisco, California. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 27648814
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Englander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian, New York, NY 10065, USA. · Department of Pathology, New York University School of Medicine, New York, NY 10016, USA. · Yale School of Medicine, New Haven, CT 06511, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Englander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian, New York, NY 10065, USA; Institute for Computational Biomedicine, Weill Medical College, New York, NY 10065, USA. · Englander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian, New York, NY 10065, USA; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA. · Center of Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Departments of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Departments of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 29153843
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Epic Sciences, La Jolla, California. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28819021
  • From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Pubmed 28785765
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. · AstraZeneca, Gaithersburg, MD, USA. · Sanofi US, Bridgewater, NJ, USA. · Pfizer Inc, New York, NY, USA. · Project Data Sphere LLC, Cary, NC, USA. · Celgene Corporation, Summit, NJ, USA. · Mayo Medical Center, Rochester, MN, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Janssen, the Pharmaceutical Companies of Johnson & Johnson, New Brunswick, NJ, USA. · Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. · Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel. · Division of Medical Oncology, Department of Medicine, Columbia University/New York Presbyterian Hospital, Manhattan, NY, USA; James J Peters VA Medical Center, Bronx, NY, USA. · Division of Medical Oncology, Department of Medicine, Columbia University/New York Presbyterian Hospital, Manhattan, NY, USA; James J Peters VA Medical Center, Bronx, NY, USA. Electronic address: · Pubmed 27979599
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: · Epic Sciences, La Jolla, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27979426
2016
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. · Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC. · Department of Medicine, Duke University Medical Center, Durham, NC. · Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Millennium Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Inc., Cambridge, MA. · Department of Urology, Weill Cornell Medical College, New York, NY; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Weill Cornell Medical College, New York, NY. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address: · Pubmed 27765518
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York · Department of Radiology, Weill Cornell Medical College, New York, New York. · Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · ImaginAb, Inc., Inglewood, California; and. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27516450
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Memorial Sloan Kettering Cancer Center, New York, New York. · Medivation, Inc., San Francisco, California. · Astellas Pharma Global Development, Inc., Northbrook, Illinois. · Virginia Oncology Associates, Norfolk, Virginia. · Pubmed 26858312
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Science, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Leonard Wagner Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065, USA. · Department of Urology, University Hospital of the Ruhr-University of Bochum, Marien Hospital Herne, Herne, Germany. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Innovagen AB, Lund, Sweden. · Department of Biochemistry, University of Turku, Turku, Finland. · Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA. · Molecular Cytology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA. · Department of Medical Radiation Physics, Lund University, Lund, Sweden. · Departments of Biology and Biomedical and Translational Sciences, Rowan University, Glassboro, NJ 08028, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, U.K. · Department of Laboratory Medicine, Lund University, Malmö, Sweden. · Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Division of Urological Research, Department of Clinical Sciences, Lund University, Malmö, Sweden. · Pubmed 27903863
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and · Pubmed 27694177
  • Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK; Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; CNIO-IBIMA Genitourinary Cancer Unit, Department of Medical Oncology, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain. · Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Medical Affairs, Janssen Diagnostics, Beerse, Belgium. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, La Jolla, CA, USA. · MIRA Research Institute for Biomedical Technology and Technical Medicine, University of Twente, Twente, The Netherlands. · Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. Electronic address: · Pubmed 27289566
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Medicine, Weill Cornell Medical College, New York, New York. · Epic Sciences, La Jolla, California. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York5Department of Radiology, Weill Cornell Medical College, New York, New York. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York6Cancer Services, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27262168
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 27025318
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York. Institute for Precision Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York. · Epic Sciences, San Diego, California. · Institute for Precision Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York. · Institute for Precision Medicine, New York Presbyterian-Weill Cornell Medicine, New York, New York. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, New York. · Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, New York. · Pubmed 26671992
  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Memorial Sloan Kettering Cancer Center, New York, NY. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, San Diego, CA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 26598756
2015
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 25544634
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America. · Lexidyne, Colorado Springs, Colorado, United States of America. · Janssen Global Services, South Raritan, New Jersey, United States of America. · Pubmed 26460686
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 25797385
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Division of Nuclear Medicine, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Division of Urological Cancers, Lund University, Lund, Sweden. · New York Oncology Hematology, Albany, New York. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26178426
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. · Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Radiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Dana-Farber Cancer Institute; Brigham & Women's Hospital; and Broad Institute, Boston, Massachusetts. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Department of Radiology, Weill Cornell Medical College, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Radiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Medicine, Weill Cornell Medical College, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26175541
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medivation Inc., San Francisco, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Pubmed 25698064
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Program, Massachusetts General Hospital, Boston, MA, USA. · Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Clinical Development, Exelixis, Inc., South San Francisco, CA, USA. · Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Genitourinary Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Urologic Surgery and Oncology, University of California San Francisco, San Francisco, CA, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Pinnacle Oncology Hematology, Scottsdale, AZ, USA. · Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24631409
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 26552950
  • 1] Department of Medicine, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Genitourinary Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Medicine, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Icahn Institute for Genomics and Multiscale Biology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Pubmed 26068399
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: · Department of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Renal Service, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 25559408
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
2014
  • From the Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, NY. · Pubmed 24857104
  • Department of Radiation Oncology, University of California, San Francisco, 1600 Divisadero Street, Suite H-1031, San Francisco, CA 94115, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA. · Pubmed 24840073
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Endocrine Sciences, LabCorp, Calabasas, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 24637537
  • Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Urologikum Hamburg, Hamburg, Germany. · Janssen Research & Development, Raritan, NJ, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Pubmed 24080993
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT, Utrecht, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 25201530
  • From the ‡Protein Center, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · From the ‡Protein Center, Memorial Sloan Kettering Cancer Center, New York, New York 10065; §Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · **Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138; · ‡‡Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · §§Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · ¶¶Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · §§Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065; ‖‖Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · §§Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065; ¶¶Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Laboratory Medicine, Lund University, University Hospital UMAS, Malmö, Sweden. · From the ‡Protein Center, Memorial Sloan Kettering Cancer Center, New York, New York 10065; §Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065; · Pubmed 25056937
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Computational Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 23954088
2013
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 23459624
2012
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY 10065, USA. · Pubmed 22894553
2011
  • Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. · Pubmed 21859988
  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 21483004
  • Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, and Weill Cornell Medical College, New York, New York, USA. · Pubmed 22046024
2010
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 20398925
2009
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 19213602
2008
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. · Pubmed 18309951
2007
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Weill Medical College of Cornell University, New York, New York, USA. · Pubmed 17332293
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From the *Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center; †Department of Medicine, Weill Cornell Medical College; and Departments of ‡Laboratory Medicine and §Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27749322
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2015
  • Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25800753
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, · Pubmed 25143071
  • From the Department of Radiology (H.A.V., C.W., J.J.F., A.W., D.A.G., S.M.L., H.H.), Department of Epidemiology and Biostatistics (D.K., M.G.), and Genitourinary Oncology Service, Department of Medicine (M.J.M., H.I.S.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and Department of Radiology, Oncology and Radiations Sciences, Section of Radiology, Nuclear Medicine and PET, Uppsala University, Uppsala, Sweden (C.W.). · Pubmed 24475817
2013
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23806501
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23337756
  • 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK [2] Memorial Sloan-Kettering Cancer Center (MSKCC) and Weill Cornell Medical College, Center for Prostate and Urologic Cancers, New York, NY, USA. · Pubmed 24169353
  • Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Mithat Gönen, Martin Fleisher, Steven M. Larson, Charles L. Sawyers, and Howard I. Scher, Memorial Sloan-Kettering Cancer Center; Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Steven M. Larson, and Howard I. Scher, Weill Cornell Medical College, New York, NY; Jeffrey H. Hager, Peter J. Rix, Edna Chow Maneval, and Isan Chen, Aragon Pharmaceuticals, San Diego, CA; and Charles L. Sawyers, Howard Hughes Medical Institute, Chevy Chase, MD. · Pubmed 24002508
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23820963
  • Authors' Affiliations: Weill Cornell Medical College (WCMC); Weill Cornell Cancer Center; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York; and University of North Carolina Chapel Hill, North Carolina. · Pubmed 23714732
  • Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 23653243
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, NY 10065, USA. · Pubmed 23535954
  • Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 23246260
  • Authors' Affiliations: Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center; Departments of Surgery, Medicine, Pathology, Biostatistics, and Immunology, Memorial Sloan-Kettering Cancer Center; NYU Langone Medical Center, New York; Department of Immunology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama; RIKEN Bioresource Center, Tsukuba, Ibaraki, Japan; and Klinik für Onkologie und Hämatologie, Krankenhaus Nordwest, Frankfurt, Germany. · Pubmed 24081977
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Pubmed 23817021
  • Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 23765638
  • Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York, USA. · Pubmed 23348745
2012
  • Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 22528368
  • Human Oncology and Pathogenesis Program and Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 22231760
  • Department of Medicine, Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, NY 10065, USA. · Pubmed 22553195
  • Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 22919006
  • Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. · Pubmed 22266222
  • Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 22231045
2011
  • Genitourinary Oncology Service, Department of Medicine and Department of Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21680546
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21802835
  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. · Pubmed 21131556
  • Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 21984797
  • Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 21604939
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 21575859
2010
  • Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 20975102
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 20217089
  • Department of Medicine, Joan and Sanford E. Weill College of Medicine of Cornell University, Ithaca, NY, USA. · Pubmed 20159814
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 21107093
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York 10022, USA. · Pubmed 20665492
  • Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 20579941
  • Department of Medicine, Clinical Genetics Service, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, Albert Einstein College of Medicine, New York, New York 10065, USA. · Pubmed 20460480
  • Clinical Genetics Service, Department of Medicine, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 20215531
  • Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 20080885
2009
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 19815486
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19375217
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19364960
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19359544
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19796750
  • Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 36, New York, NY 10065, USA. · Pubmed 19628766
  • Molecular Cytogenetics Core Laboratory, Department of Medicine, Memorial Sloan-kettering Cancer Center, New York, New York, USA. · Pubmed 19276271
  • Departments of Surgery (Urology Service), Memorial Sloan-Kettering Cancer Center,New York, NY 10065, USA. · Pubmed 19233911
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 19213669
  • Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. · Pubmed 19190343
  • Department of Surgery (Urology Service), Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 19003994
2008
  • Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 18674639
  • Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 18565882
  • Nuclear Medicine Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 18552139
  • Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 18362364
  • Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 18661513
2007
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 17925542
  • Department of Medicine (Genitourinary Oncology Service), Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 17936848
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. · Pubmed 17619878
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. · Pubmed 18056182
  • Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 17761958
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 17557117
Cornell University
2017
  • Sage Bionetworks, Seattle, WA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Mathematics and Statistics, University of Turku, Turku, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. · Department of Information Technology, University of Turku, Turku, Finland. · Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; Department of Pathology (HUSLAB), Helsinki University Hospital, Helsinki, Finland. · Sanofi, Bridgewater, NJ, USA. · AstraZeneca, Gaithersburg, MD, USA. · IBM T J Watson Research Center, IBM, Yorktown Heights, NY, USA. · Prostate Cancer Foundation, Santa Monica, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Genitourinary Medical Oncology Program, Division of Hematology and Oncology, University of California, San Francisco, CA, USA. · Genitourinary Oncology Services, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA; The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Department of Pharmacology and Computational Biosciences Program, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: · Pubmed 27864015
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Epic Sciences, La Jolla, California. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28819021
  • From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Pubmed 28785765
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: · Epic Sciences, La Jolla, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 27979426
2016
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. · Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC. · Department of Medicine, Duke University Medical Center, Durham, NC. · Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Millennium Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Inc., Cambridge, MA. · Department of Urology, Weill Cornell Medical College, New York, NY; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. · Department of Medicine, Weill Cornell Medical College, New York, NY. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address: · Pubmed 27765518
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York · Department of Radiology, Weill Cornell Medical College, New York, New York. · Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York. · Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · ImaginAb, Inc., Inglewood, California; and. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27516450
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Science, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Leonard Wagner Laboratory of Molecular Genetics and Immunology, Rockefeller University, New York, NY 10065, USA. · Department of Urology, University Hospital of the Ruhr-University of Bochum, Marien Hospital Herne, Herne, Germany. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Innovagen AB, Lund, Sweden. · Department of Biochemistry, University of Turku, Turku, Finland. · Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA. · Molecular Cytology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Radiochemistry and Imaging Sciences Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA. · Department of Medical Radiation Physics, Lund University, Lund, Sweden. · Departments of Biology and Biomedical and Translational Sciences, Rowan University, Glassboro, NJ 08028, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, U.K. · Department of Laboratory Medicine, Lund University, Malmö, Sweden. · Nuclear Medicine Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Division of Urological Research, Department of Clinical Sciences, Lund University, Malmö, Sweden. · Pubmed 27903863
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Medicine, Weill Cornell Medical College, New York, New York. · Epic Sciences, La Jolla, California. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York5Department of Radiology, Weill Cornell Medical College, New York, New York. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York6Cancer Services, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland. · Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 27262168
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 27025318
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY · Memorial Sloan Kettering Cancer Center, New York, NY. · Janssen Research & Development, Menlo Park, CA. · Janssen Research & Development, San Diego, CA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 26598756
2015
  • Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 25544634
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America. · Lexidyne, Colorado Springs, Colorado, United States of America. · Janssen Global Services, South Raritan, New Jersey, United States of America. · Pubmed 26460686
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Weill Cornell Medical College, New York, New York. · Division of Nuclear Medicine, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Division of Urological Cancers, Lund University, Lund, Sweden. · New York Oncology Hematology, Albany, New York. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26178426
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. · Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Radiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Dana-Farber Cancer Institute; Brigham & Women's Hospital; and Broad Institute, Boston, Massachusetts. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Department of Radiology, Weill Cornell Medical College, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. Radiochemistry and Molecular Imaging Probe Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Medicine, Weill Cornell Medical College, New York, New York. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Department of Radiology, Weill Cornell Medical College, New York, New York. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 26175541
  • University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medivation Inc., San Francisco, CA, USA. · Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Pubmed 25698064
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weil Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Program, Massachusetts General Hospital, Boston, MA, USA. · Cancer Outcomes Research Program, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Clinical Development, Exelixis, Inc., South San Francisco, CA, USA. · Genitourinary Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. · Genitourinary Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA. · Urologic Surgery and Oncology, University of California San Francisco, San Francisco, CA, USA. · Tulane Cancer Center, Tulane University, New Orleans, LA, USA. · Pinnacle Oncology Hematology, Scottsdale, AZ, USA. · Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey, UK. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24631409
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: · Janssen Research and Development, Los Angeles, CA, USA. · Janssen Research and Development, Menlo Park, CA, USA. · Janssen Research and Development, Raritan, NJ, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Institut Gustave Roussy, Villejuif, France. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, UK. · Pubmed 25018037
2014
  • From the Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical College, New York, NY. · Pubmed 24857104
  • Department of Radiation Oncology, University of California, San Francisco, 1600 Divisadero Street, Suite H-1031, San Francisco, CA 94115, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA. · Pubmed 24840073
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Endocrine Sciences, LabCorp, Calabasas, CA, USA. · Memorial Sloan Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 24637537
  • Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Urologikum Hamburg, Hamburg, Germany. · Janssen Research & Development, Raritan, NJ, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Pubmed 24080993
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT, Utrecht, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 25201530
  • Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Computational Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: · Pubmed 23954088
2012
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY 10065, USA. · Pubmed 22894553
2011
  • Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, and Weill Cornell Medical College, New York, New York, USA. · Pubmed 22046024
2007
  • Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Weill Medical College of Cornell University, New York, New York, USA. · Pubmed 17332293
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • From the *Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center; †Department of Medicine, Weill Cornell Medical College; and Departments of ‡Laboratory Medicine and §Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 27749322
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
2015
  • Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25800753
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
2014
  • Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Matthew R. Smith, Massachusettes General Hospital; Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA; Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI; Daniel J. George, Duke University Medical Center, Durham; Ethan M. Basch, University of North Carolina, Chapel Hill, NC; Celestia S. Higano, University of Washington, Seattle, WA; Andrea L. Harzstark, University of California San Francisco, San Francisco; Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA; A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
2013
  • 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK [2] Memorial Sloan-Kettering Cancer Center (MSKCC) and Weill Cornell Medical College, Center for Prostate and Urologic Cancers, New York, NY, USA. · Pubmed 24169353
  • Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Mithat Gönen, Martin Fleisher, Steven M. Larson, Charles L. Sawyers, and Howard I. Scher, Memorial Sloan-Kettering Cancer Center; Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Steven M. Larson, and Howard I. Scher, Weill Cornell Medical College, New York, NY; Jeffrey H. Hager, Peter J. Rix, Edna Chow Maneval, and Isan Chen, Aragon Pharmaceuticals, San Diego, CA; and Charles L. Sawyers, Howard Hughes Medical Institute, Chevy Chase, MD. · Pubmed 24002508
  • Authors' Affiliations: Weill Cornell Medical College (WCMC); Weill Cornell Cancer Center; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York; and University of North Carolina Chapel Hill, North Carolina. · Pubmed 23714732
  • Memorial Sloan-Kettering Cancer Center, New York; Weill Cornell Medical College, New York, NY; Knight Cancer Institute, Oregon Health & Science University, Portland, OR; Duke University Medical Center, Durham; Cancer Outcomes Research Program, University of North Carolina, Chapel Hill, NC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore; US Food and Drug Administration, Silver Spring, MD; and University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 23943897
2010
  • Department of Medicine, Joan and Sanford E. Weill College of Medicine of Cornell University, Ithaca, NY, USA. · Pubmed 20159814
NewYork-Presbyterian Hospital
2014
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, 3584 CT, Utrecht, The Netherlands. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Institute for Precision Medicine of Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA. · Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Pubmed 25201530
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
56 Other Locations Show
Yearly article counts 091721162020101616714
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.